Bio-Safety and Bioethics
Biosafety as currently discussed in the International “Convention on Biological Diversity” (CBD) and designed to create internationally binding protocols on biosafety. The application of biotechnology to food and agriculture can bring not only potential risks and benefits as any technology can, but also concerns about the human dimensions coupled with biotechnology. These include both positive and negative impacts on stake holders, social institutions, economy and communities. Different areas associated with biosafety include: (i) Agriculture and food system issues (ii) Market and consumer issues (iii) Institutional issues, business issues and (iv) Social issues. Biosafety is the prevention of large-scale loss of biological integrity, focusing both on ecology and human health. These prevention mechanisms include conduction of regular reviews of the biosafety in laboratory settings, as well as strict guidelines to follow. The international Cartagena Protocol on Biosafety deals primarily with the agricultural definition but many advocacy groups seek to expand it to include post-genetic threats: new molecules, artificial life forms, and even robots which may compete directly in the natural food chain. ‘Biosafety’ means the need to protect human and animal health and environment from the possible adverse effects of the products of modern biotechnology. Bioethics is the study of the typically controversial ethical issues emerging from new situations and possibilities brought about by advances in biology and medicine. It is also moral discernment as it relates to medical policy and practice. Bioethicists are concerned with the ethical questions that arise in the relationships among life sciences, biotechnology, medicine, politics, law, and philosophy. The scope of bioethics can expand with biotechnology, including cloning, gene therapy, life extension, human genetic engineering, astroethics and life in space, and manipulation of basic biology through altered DNA, XNA and proteins. These developments will affect future evolution, and may require new principles that address life at its core, such as biotic ethics that values life itself at its basic biological processes and structures, and seeks their propagation.
Related Conference of Bio-Safety and Bioethics
Bio-Safety and Bioethics Conference Speakers
Recommended Sessions
- Animal Biotechnology
- Applied Biotechnology
- Bio-Safety and Bioethics
- Bioinformatics and Biomedicine Engineering
- Biomedical Engineering and Bio-Engineering
- Enzyme and Protein Engineering
- Food & Feed Biotechnology
- Genetic Engineering and Tissue Engineering
- Industrial and Microbial Biotechnology
- Marine, Aquatic and Ocean Biotechnology
- Medicine & Biotechnology
- Molecular Biotechnology
- Nano biotechnology
- Pharmaceutical Biotechnology
- Plant, Agriculture and Environment Biotechnology
Related Journals
Are you interested in
- Advances in Separation Techniques - ANALYTICA ACTA 2024 (France)
- Analytical Chemistry and Methodology - ANALYTICA ACTA 2024 (France)
- Analytical Technique for Clinical Chemistry - ANALYTICA ACTA 2024 (France)
- Analytical Technique for Thermal analysis - ANALYTICA ACTA 2024 (France)
- Bioanalytical Methodology - ANALYTICA ACTA 2024 (France)
- Biochemistry - ANALYTICA ACTA 2024 (France)
- Biomarkers & Next-Generation Sequencing - Biomarkers 2024 (UK)
- Biomarkers based on epidemiological investigations - Biomarkers 2024 (UK)
- Biomarkers for Cancer Diagnosis - Biomarkers 2024 (UK)
- Biomarkers for Early Diagnosis and Prognosis - Biomarkers 2024 (UK)
- Biomarkers for non-cancerous diseases - Biomarkers 2024 (UK)
- Biomarkers in Diagnosis: Challenges and Approaches - Biomarkers 2024 (UK)
- Biomarkers in Disease Treatment - Biomarkers 2024 (UK)
- Biomarkers in Drug discovery and development - Biomarkers 2024 (UK)
- Biomarkers in Immune-Oncology - Biomarkers 2024 (UK)
- Biomarkers of Cardiovascular disorders - Biomarkers 2024 (UK)
- Biomarkers of Disorders of the Nervous System - Biomarkers 2024 (UK)
- Biomarkers: Validation & Verification - Biomarkers 2024 (UK)
- Biopolymers and Biomaterials - ANALYTICA ACTA 2024 (France)
- Chromatography - ANALYTICA ACTA 2024 (France)
- Clinical and Biomedical Engineering - Biomarkers 2024 (UK)
- Clinical Diagnostics Equipment and Kits - ANALYTICA ACTA 2024 (France)
- Clinical Research & Biomarkers - Biomarkers 2024 (UK)
- Discovery of new biomarkers/validation/technologies - Biomarkers 2024 (UK)
- Electrophoresis - ANALYTICA ACTA 2024 (France)
- Entrepreneur Investments Meet - Biomarkers 2024 (UK)
- Environmental Analytical Chemistry - ANALYTICA ACTA 2024 (France)
- Genomic Biomarkers in Clinical Development - Biomarkers 2024 (UK)
- Hyphenated Techniques - ANALYTICA ACTA 2024 (France)
- Imaging Technologies and Diagnostic tests of Biomarkers - Biomarkers 2024 (UK)
- Innovation in Food Analysis & Testing - ANALYTICA ACTA 2024 (France)
- Mass Spectrometry - ANALYTICA ACTA 2024 (France)
- Method development and validation - ANALYTICA ACTA 2024 (France)
- Microscopy - ANALYTICA ACTA 2024 (France)
- New Instrumentation and Equipment - ANALYTICA ACTA 2024 (France)
- Novel Optical Sensors and Biosensors - ANALYTICA ACTA 2024 (France)
- Pharmaceutical Analytics - ANALYTICA ACTA 2024 (France)
- Polymer Science and Material Science - ANALYTICA ACTA 2024 (France)
- Proteomics and its applications - ANALYTICA ACTA 2024 (France)
- Regulatory Issues and Biosafety Challenges in Bioanalysis - ANALYTICA ACTA 2024 (France)
- Regulatory issues and Biosafety challenges in bioanalysis - ANALYTICA ACTA 2024 (France)
- Spectroscopy - ANALYTICA ACTA 2024 (France)